Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of a cancer genomic profile test for patients with metastatic breast cancer.

Scientific reports - 21 Mar 2022

Fukada Ippei, Mori Seiichi, Hayashi Naomi, Hosonaga Mari, Yamazaki Masumi, Wang Xiaofei, Kawai Saori, Inagaki Lina, Ozaki Yukinori, Kobayashi Kokoro, Hara Fumikata, Kobayashi Takayuki, Ueki Arisa, Osako Tomo, Tonooka Akiko, Takeuchi Kengo, Ueno Takayuki, Takano Toshimi, Ohno Shinji, Takahashi Shunji

Abstract excerpt

Comprehensive cancer genomic profile (CGP) tests are being implemented under Japanese universal health insurance system. However, the clinical usefulness of CGP test for breast cancer patients has not been evaluated. Of the 310 patients who underwent CGP testing at our institution between November 2019 and April 2021, 35 patients with metastatic breast cancer whose treatment strategy was discussed by our...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Profile

Share to Genomics

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 35315838
DOI: 10.1038/s41598-022-08925-3
PMCID: PMC8938506

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of a cancer genomic profile test for patients with metastatic breast cancer.PMID 35315838Read ↗

Initial assessment of a cancer genomic profile test for patients with metastatic breast cancer: a retrospective studySemantic proximity Read ↗

Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice.Semantic proximity Read ↗

Real-World Landscape of Genomic Medicine in Breast Cancer Revealed by the C-CAT Database: Reappraisal of Drug Accessibility and Clinical Utility in 6,307 PatientsSemantic proximity Read ↗

Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.Semantic proximity Read ↗

Comprehensive Genomic Profiling of Taiwanese Breast Cancer Using a Novel Targeted Sequencing PanelSemantic proximity Read ↗

Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, JapanSemantic proximity Read ↗

Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancerSemantic proximity Read ↗

Cancer genomic medicine in JapanSemantic proximity Read ↗

Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancerSemantic proximity Read ↗

Clinical Utility of Comprehensive Genomic Profiling Tests Using MTB Management System at a Single Center in JapanSemantic proximity Read ↗

Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.Semantic proximity Read ↗

<p class="MDPI12titleori1" style="mso-line-height-alt: 14.0pt;"><span style="mso-bidi-font-size: 18.0pt; mso-bidi-font-weight: bold;">MammaPrint™ Genetic Signature in the Brazilian Population, Analysis of Results and Clinical Outcomes (AGEMA-BRA) – Real World StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.